M
Molecular NeuroImaging
Specialized imaging and eClinical solutions for biopharmaceuticals
About Molecular NeuroImaging
Perceptive offers specialized support for global pharmaceutical, biotech, and clinical research organizations across the entire R&D lifecycle. The company's services include imaging biomarkers, core lab services, and technologies for randomization and trial supply management (RTSM). The entity known today as Perceptive has a complex history involving several strategic mergers, acquisitions, and rebrandings. The journey begins with companies like Molecular NeuroImaging (MNI), Perceptive Informatics, and PAREXEL. MNI was founded in 2000 by Ken Marek and John Seibyl, specializing in neuroimaging services for drug development. Perceptive Informatics operated as a subsidiary of PAREXEL International, providing a suite of eClinical solutions including medical imaging, RTSM, and clinical trial management systems (CTMS). In 2016, inviCRO, a provider of imaging services, acquired MNI to create a full-service translational imaging provider. A year later, in 2017, Pamplona Capital Management acquired PAREXEL International, which included its Perceptive Informatics division. In January 2021, PAREXEL separated its Informatics and Medical Imaging business, which was then launched as an independent company named Calyx. Calyx was subsequently acquired by GLO Healthcare, a platform created by CapVest Partners. Later, Calyx acquired inviCRO, further expanding its biomarker capabilities. In February 2024, Ennov acquired the 'Enterprise Technology' division from Calyx, which included its regulatory information management solutions. Finally, in September 2024, the remaining Calyx and inviCRO businesses rebranded to become Perceptive. Perceptive operates on a business-to-business model, serving biopharmaceutical and clinical research organizations. Its revenue is generated by providing a range of services and technology solutions that support clinical trials from the preclinical phase to post-marketing. These offerings are structured into several key areas: Perceptive Discovery for preclinical imaging, Perceptive eClinical for trial management technologies like IRT/RTSM, and Perceptive Imaging which serves as an imaging core lab for clinical trials. The company has supported over 400 regulatory approvals and has a global presence with offices in North America, Europe, and Asia.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2000
- Headquarters
- New Haven, United States
- Employees
- 1,286
- Open positions
- None listed
- Dealroom signal
- 37.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Biomarkers, Clinical, Medical Imaging, Techbio, DT and LS
- Technology
- Big Data, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2026 | $15M | $60M | CapVest | ↗ |
Growth signals
Latest recorded traffic for Molecular NeuroImaging is 23K monthly website visits, down 8% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Molecular NeuroImaging in the New Haven ecosystem
The Molecular NeuroImaging office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
CapVest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Molecular NeuroImaging on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Molecular NeuroImaging’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








